Publications

Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47

 63
Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47

Tags:

Previous Article

Opposing roles for AMPK in regulating distinct mitophagy pathways

Next Article

Gene replacement therapy for hereditary spastic paraplegia type 47

Related Posts

ATG9A and ARFIP2 cooperate to control PI4P levels for lysosomal repair

ATG9A and ARFIP2 cooperate to control PI4P levels for l...

 51

Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer

Convergent alterations in the tumor microenvironment of...

 51

Extracellular vesicle-mediated trafficking of molecular cues during human brain development

Extracellular vesicle-mediated trafficking of molecular...

 52